Karen Wagner
Ysios Capital patner
Management
Aelix Therapeutics
Spain
Biography
Dr. Karen Wagner is a General Partner at Ysios Capital where she focuses on therapeutic investments. Dr. Wagner currently serves on the boards of AELIX Therapeutics and Vivet Therapeutics and is an observer on the board of Minoryx Therapeutics.  Dr. Wagner holds a master’s degree in Molecular Biology and a PhD in Cell Biology, both from the University of Konstanz, Germany. Dr. Wagner has over 15 years of experience in business development and financing in the biotech/pharma sector working for companies such as F. Hoffmann-La Roche and GlycArt. Previously she was a Consultant in McKinsey & Company’s Global Healthcare Practice.
Research Interest
Pharma
